# Medipal Holdings

> Medipal Holdings is a VC fund in Tokyo backing Health Care and Medical. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 7
- Last investment: Aug 2024
- Lead investor: 14%
- Last updated: Aug 2026
- Website: https://www.medipal.co.jp/

Medipal Holdings is a holding company that engages in the sale of pharmaceuticals, cosmetics, and daily necessities. The company is founded on October 8, 1898, and is headquartered in Tokyo, Japan.

## Contacts

5 contacts available for Medipal Holdings. Shizune tracks 3 team members at Medipal Holdings. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/medipal-holdings?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 57% |
| Medical | 2 | 29% |
| Biotechnology | 2 | 29% |
| Medical Device | 2 | 29% |
| Beauty | 1 | 14% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Corporate Round | 3 | 43% |
| Series B | 1 | 14% |
| Series C | 1 | 14% |
| Funding Round | 1 | 14% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Toshihide Yoda | Director | 1 | https://shizune.co/investors/profile/toshihide-yoda |
| Kazuo Hashida | Executive Officer, Director of Finance & Accounting | 0 | https://shizune.co/investors/profile/kazuo-hashida |
| Shuichi Watanabe | Representative Director, President and CEO | 0 | https://shizune.co/investors/profile/shuichi-watanabe |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| N.B.Medical | N.B.Medical is a medical equipment manufacturer that specializes in the development of next-generation neurovascular devices and in-silico regulatory technologies. The compant integrates real-world medical device development with regulation-integrated CMS and AI-driven digital-twin technologies to establish a proprietary development model. | $13.7M | Series B | Aug 30, 2024 |  |
| Heartseed | Heartseed is a biotechnology research firm that specializes in the development of purified ventricular cardiomyocytes derived from induced pluripotent stem cells for the treatment of heart failure. The company employs an innovative methodology that involves the creation of cardiomyocyte spheroids, small clusters of heart cells, using stem cells.These spheroids are then surgically implanted into the heart to improve its performance. | $37M | Series C | Jun 11, 2021 |  |
| Heartseed | Heartseed is a biotechnology research firm that specializes in the development of purified ventricular cardiomyocytes derived from induced pluripotent stem cells for the treatment of heart failure. The company employs an innovative methodology that involves the creation of cardiomyocyte spheroids, small clusters of heart cells, using stem cells.These spheroids are then surgically implanted into the heart to improve its performance. | $955.3K | Corporate Round | Mar 10, 2020 |  |
| CLIPLA | CLIPLA recognizes the importance of protecting personal information and the social nature of medical-related businesses. | $66.6M | Corporate Round | Mar 13, 2018 |  |
| Scohia Pharma | Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic. | $1.4B | Corporate Round | Mar 14, 2017 |  |
| FunPep | FunPep is an Industry-university collaboration bioventure company. | $35.4M |  | Apr 14, 2016 |  |
| FunPep | FunPep is an Industry-university collaboration bioventure company. |  |  |  |  |

7 of 7 investments shown.

## Co-investors
- [ITOCHU Chemical Frontier](https://shizune.co/investors/profile/itochu-chemical-frontier-corporation) — VC Fund, 2 deals together
- [Bio-sight Capital](https://shizune.co/investors/profile/bio-sight-capital) — VC Fund, 1 deal together
- [Dainippon Sumitomo Pharma](https://shizune.co/investors/profile/dainippon-sumitomo) — VC Fund, 1 deal together
- [FANCL](https://shizune.co/investors/profile/fancl) — VC Fund, 1 deal together
- [Innovation Network Corporation of Japan](https://shizune.co/investors/profile/innovation-network-corp-of-japan) — VC Fund, 1 deal together
- [Keio Innovation Initiative](https://shizune.co/investors/profile/keio-innovations-initiative) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Info Edge](https://shizune.co/investors/profile/info-edge) — VC Fund
- [Vector](https://shizune.co/investors/profile/vector-inc-) — VC Fund
- [Akatsuki Games Inc.](https://shizune.co/investors/profile/akatsuki-3) — VC Fund

## FAQ

### What does Medipal Holdings invest in?

Medipal Holdings invests primarily in Health Care, Medical and Biotechnology startups, most often at Corporate Round and Series B stage. Most of the 7 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Medipal Holdings?

Public channels for Medipal Holdings include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Medipal Holdings?

The team at Medipal Holdings includes Toshihide Yoda (Director), Kazuo Hashida (Executive Officer, Director of Finance & Accounting) and Shuichi Watanabe (Representative Director, President and CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co